FDA — authorised 7 July 2014
- Application: NDA204427
- Marketing authorisation holder: ANACOR PHARMS INC
- Local brand name: KERYDIN
- Indication: SOLUTION — TOPICAL
- Status: approved
🇺🇸 Tavaborole 5% Topical Solution in United States
FDA authorised Tavaborole 5% Topical Solution on 7 July 2014
Marketing authorisation
Frequently asked questions
Is Tavaborole 5% Topical Solution approved in United States?
Yes. FDA authorised it on 7 July 2014.
Who is the marketing authorisation holder for Tavaborole 5% Topical Solution in United States?
ANACOR PHARMS INC holds the US marketing authorisation.